ERBB3 and cancer: On the contrary, decreased levels of neuregulin 1 (NRG1), a direct ligand of ERBB3 and ERBB4 tyrosine kinase receptors, which activate ERBB receptors, could be responsible for the inhibition of cancer cell growth.